Breaking News on Biopharmaceutical Development & Manufacturing

Top Headlines

Pfizer’s ADC ambition bolstered by US Besponsa approval

Pfizer has been granted US approval for its antibody-drug conjugate (ADC) Besponsa, to be manufactured at the firm’s Pearl River, New York facility.

Oxford Genetics secures investment; expands UK facility and eyes US market

Oxford Genetics will expand its bioproduction services in the UK and target the US market through an office in Boston after receiving a £7.5m ($9.6m) investment.

Gone to the dogs? Shire sells vaccine plant to Merck Animal Health

Shire has sold the former Baxalta vaccine facility in Austria to Merck Animal Health for an undisclosed fee.

Samsung Bioepis teams with Takeda to take first steps into novel biologics space

Samsung Bioepis says it will continue focusing on biosimilars as it ventures into the innovative biologics space through a partnership with Takeda.

AstraZeneca ups its mRNA stake through €25m Ethris deal

AstraZeneca has entered a five-year collaboration to develop therapies for respiratory diseases based on Ethris’ messenger RNA (mRNA) technology.

VistaGen’s cell production methods receive US patent boost

VistaGen Therapeutics has received a notice of allowance for a stem cell production patent, which the firm says could be used in autoimmune disorder and cancer treatments.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...